In a major achievement, Pakistan has successfully manufactured a COVID vaccine locally at the National Institute of Health (NIH) Islamabad.
Overall 124,000 doses of single-dose CanSino vaccine were manufactured at the NIH and would be available for use from the next week. The vaccine was prepared by Pakistani experts under the supervision of a Chinese team, and the second batch of the vaccine will be prepared solely by the Pakistani experts. The Chinese team assisted during the manufacturing process with the raw material provided by the Chinese firm CanSino.
The quality control division of the NIH is currently examining the locally manufactured COVID vaccine and initial trials have proved it is safe to be administered. The National Control Lab for Biologicals of the DRAP will examine the vaccine and give a final approval regarding its use.
The doses will be supplied nationwide soon after receiving DRAPΓÇÖs approval.
GET YOURSELF VACCINATED- STAY HEALTHY and STAY SAFE